Disease Burden and Biology Using Tumor Cell Free DNA in Metastatic Kidney Cancer
- Status
- COMPLETED
- Phase
- N/A
Clinical Trials Related to Renal Cell Carcinoma
Related studies linked through entity extraction aliases.
Significance of Immunohistochemical Expression of Survivin in Renal Cell Carcinoma
- Status
- COMPLETED
- Phase
- N/A
A Study of HC-5404-FU to Establish the Maximum Tolerated Dose (MTD)
- Status
- COMPLETED
- Phase
- PHASE1
Non-Contrast Perfusion Using Arterial Spin Labeled MR Imaging for Assessment of Therapy Response in Metastatic Renal Cell Carcinoma
- Status
- TERMINATED
- Phase
- NA
Survey of Cabozantinib Used To Treat People With Renal Cell Carcinoma
- Status
- COMPLETED
- Phase
- N/A
Research on the Effectiveness and Safety of Remote Control of Domestic Surgical Robot System for Urinary Surgery
- Status
- COMPLETED
- Phase
- EARLY_PHASE1
The Evaluation of Functional Parenchymal Volume and Split Renal Function Before and After Partial Nephrectomy
- Status
- UNKNOWN
- Phase
- NA
Frequency and Clinical Phenotype of BAP1 Hereditary Predisposition Syndrome
- Status
- RECRUITING
- Phase
- N/A
Phase 1a and Phase 2 Study for Safety, Preliminary Efficacy, PK and PD of ST-067
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
Fecal Microbiota Transplantation to Improve Efficacy of Immune Checkpoint Inhibitors in Renal Cell Carcinoma
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
A Study of DS-6000a in Subjects With Advanced Renal Cell Carcinoma and Ovarian Tumors
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
Pembrolizumab Plus Lenvatinib for First-line Advanced/Metastatic Non-clear Cell Renal Cell Carcinoma (1L nccRCC) (MK-3475-B61)
- Status
- COMPLETED
- Phase
- PHASE2
A Study of PY314 in Subjects With Advanced Solid Tumors
- Status
- TERMINATED
- Phase
- PHASE1
iConquerFear Program for the Treatment of Fear of Cancer Recurrence in Patients With Localized Renal Cell Carcinoma
- Status
- WITHDRAWN
- Phase
- N/A
To Examine the Effects of Axitinib Dose Reduction and Interruption for Adverse Event Management Among Patients Receiving Axitinib in for the Treatment of Advanced Renal Cell Carcinoma
- Status
- COMPLETED
- Phase
- N/A
Evaluating the Bacterial and Fungal Microbiome in Patients With Calcium Oxalate Urolithiasis and Renal Cell Carcinoma
- Status
- SUSPENDED
- Phase
- N/A
VETC, Prognostic and Predictive Value in Renal Cell Carcinoma and Adrenal Carcinoma
- Status
- UNKNOWN
- Phase
- N/A
Real-world Treatment Patterns and Outcomes Among aRCC Patients on Cabozantinib or Axitinib in England
- Status
- COMPLETED
- Phase
- N/A
Risk Factors of Immune-ChEckpoint Inhibitors MEdiated Liver, Gastrointestinal, Endocrine and Skin Toxicity
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
Study of INCB086550 in Select Solid Tumors
- Status
- TERMINATED
- Phase
- PHASE2